Ginkgo Bioworks
DNA
$0.04 (-4.32%)
1D
1W
3M
1Y
5Y
ALL
Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
InvestorPlace • 7 hours ago • DNA
3 Meme Stocks to Sell in May Before They Crash & BurnInvestorPlace • 1 day ago • DNA
Want $10,000? Invest $1,000 in These 3 Penny Stocks NowPRNewsWire • 2 days ago • DNA
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel SweetenerPRNewsWire • 3 days ago • DNA
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual MeetingPRNewsWire • 7 days ago • DNA
Ginkgo Bioworks Announces Date of First Quarter 2024 Results PresentationCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.